SCHEDULE 13D FOR SOUNDVIEW ASSET MANAGEMENT

Company

Lineage Cell Therapeutics, Inc.

Filed

April 17, 1996

Accession Number

0000896058-96-000043

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →